Eunice Kennedy Shrive National Institute of Child Health and Human Development; Notice of Committee Establishment, 14520 [2017-05486]
Download as PDF
14520
Federal Register / Vol. 82, No. 53 / Tuesday, March 21, 2017 / Notices
submit an annual report for devices
distributed under the custom device
exemption.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses per
respondent
Total
annual
responses
Average
burden per
response
Total hours
Annual reporting for custom devices ...................................
33
1
33
40
1,320
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: March 15, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–05349 Filed 3–20–17; 8:45 am]
BILLING CODE 4164–01–P
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
[FR Doc. 2017–05487 Filed 3–20–17; 8:45 am]
Dated: March 13, 2017.
Leslie Kux,
Associate Commissioner for Policy.
Dated: March 15, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Mental Health Services Research Conflicts.
Date: April 7, 2017.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
16:47 Mar 20, 2017
Jkt 241001
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
VerDate Sep<11>2014
[FR Doc. 2017–05486 Filed 3–20–17; 8:45 am]
Eunice Kennedy Shrive National
Institute of Child Health and Human
Development; Notice of Committee
Establishment
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
App.), the Director, National Institutes
of Health (NIH), announces the
establishment of the Task Force on
Research Specific to Pregnant Women
and Lactating Women (Task Force) as
required by section 2041 of the 21st
Century Cures Act, Public Law 114–255.
The Task Force will provide advice
and guidance to the Secretary,
Department of Health and Human
Services (Secretary), regarding Federal
activities related to identifying and
addressing gaps in knowledge and
research regarding safe and effective
therapies for pregnant women and
lactating women, including the
development of such therapies and the
collaboration on and coordination of
such activities. The Task Force will, not
later than 18 months after the
establishment, prepare and submit a
report to the Secretary, the Committee
on Health, Education, Labor and
Pensions of the Senate, and the
Committee on Energy and Commerce of
the House of Representatives.
It is determined that the Task Force is
in the public interest in connection with
the performance of duties imposed on
the NIH by statute, and that these duties
can best be performed through the
advice and counsel of this group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
National Institutes of Health
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on April
26–27, 2017. The topic for this meeting
will be ‘‘Opportunities for Research
Supported by the Special Statutory
Funding Program for Type 1 Diabetes
Research.’’ The meeting is open to the
public. Non-federal individuals
planning to attend the workshop should
register by email to Charlemae Clarke,
The Scientific Consulting Group, Inc.
(cclarke@scgcorp.com; please put
‘‘Registration DMICC T1D Meeting’’ in
the subject line) at least 7 days prior to
the workshop.
DATES: The meeting will be held on
April 26, 2017 from 8:00 a.m. to 5:45
p.m. and on April 27, 2017 from 8:00
a.m. to 3:00 p.m.
ADDRESSES: The meeting will be held in
the Conference Room (terrace level) at
5635 Fishers Ln., Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: An
agenda for the DMICC meeting will be
available by contacting Charlemae
Clarke, The Scientific Consulting Group,
Inc. (cclarke@scgcorp.com; please put
‘‘Agenda Request for DMICC T1D
Meeting’’ in the subject line). For further
information concerning this meeting,
contact Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
SUMMARY:
E:\FR\FM\21MRN1.SGM
21MRN1
Agencies
[Federal Register Volume 82, Number 53 (Tuesday, March 21, 2017)]
[Notices]
[Page 14520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05486]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shrive National Institute of Child Health and
Human Development; Notice of Committee Establishment
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. App.), the Director, National Institutes of Health (NIH),
announces the establishment of the Task Force on Research Specific to
Pregnant Women and Lactating Women (Task Force) as required by section
2041 of the 21st Century Cures Act, Public Law 114-255.
The Task Force will provide advice and guidance to the Secretary,
Department of Health and Human Services (Secretary), regarding Federal
activities related to identifying and addressing gaps in knowledge and
research regarding safe and effective therapies for pregnant women and
lactating women, including the development of such therapies and the
collaboration on and coordination of such activities. The Task Force
will, not later than 18 months after the establishment, prepare and
submit a report to the Secretary, the Committee on Health, Education,
Labor and Pensions of the Senate, and the Committee on Energy and
Commerce of the House of Representatives.
It is determined that the Task Force is in the public interest in
connection with the performance of duties imposed on the NIH by
statute, and that these duties can best be performed through the advice
and counsel of this group.
Inquiries may be directed to Jennifer Spaeth, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
spaethj@od.nih.gov.
Dated: March 15, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-05486 Filed 3-20-17; 8:45 am]
BILLING CODE 4140-01-P